Periodic Delivery of Medicinal Products According to the Attached Specification for the Needs of Mbal - Asenovgrad Eood - Part Iv

BulgariaTenders notice for Periodic Delivery of Medicinal Products According to the Attached Specification for the Needs of Mbal - Asenovgrad Eood - Part Iv. The reference ID of the tender is 115829179 and it is closing on 03 Apr 2025.

100% Secure Payments

Tender Details

  • Country: Bulgaria
  • Summary: Periodic Delivery of Medicinal Products According to the Attached Specification for the Needs of Mbal - Asenovgrad Eood - Part Iv
  • BGT Ref No: 115829179
  • Deadline: 03 Apr 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 4190000
  • Notice Type: Tender
  • Document Ref. No.: 01036-2025-0004
  • Purchaser's Detail :
  • Purchaser : MULTIPROFILE HOSPITAL FOR ACTIVE TREATMENT - ASENOVGRAD LTD.
    Bulgaria
    Nikoleta Kirilova Hristeva-Vasileva
    Email :nikoleta_hristeva@abv.bg

  • Description :
  • Periodic delivery of medicinal products according to the attached specification for the needs of MBAL - Asenovgrad EOOD - Part IV
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
BulgariaTenders Features

BulgariaTenders Features

Fresh and verified Tenders from Bulgaria. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Bulgaria in your email inbox.

  Chat with us